HR 8553 United States House · 119th Congress

POPCaP Authorization Act of 2026

This bill establishes a new Precision Oncology Program for Prostate Cancer within the Department of Veterans Affairs to provide specialized care and research for veterans diagnosed with prostate or related genitourinary cancers. The legislation authorizes the creation of at least 21 designated Centers of Excellence across the country, each required to offer genetic sequencing, clinical trials, and specialized medical staff to treat eligible veterans. A dedicated leadership team will coordinate these centers, maintain a national data registry, and develop uniform tools to standardize care and research efforts. The program includes a five-year funding authorization of $15.5 million annually and mandates that existing prostate cancer resources at these facilities remain protected until 2030. Additionally, the bill requires the Secretary of Veterans Affairs to submit detailed implementation plans and annual performance reports to Congress to ensure accountability.
Bill status in committee 1 of 4 stages cleared
Introduction
Apr 2026
Committee Review
Floor Vote
President
Introduced Apr 28, 2026 Last action Jun 12, 2026
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
3
Key actions
0
Committee
2
Jun 12, 2026
Committee
Referred to the Subcommittee on Health.
lower
Apr 28, 2026
Committee
Referred to the House Committee on Veterans' Affairs.
lower
Apr 28, 2026
Introduced
Introduced in House
lower
1 primary · 2 co-sponsors

Sponsors